ASCT Use & Timing Can Be Tailored in Newly Diagnosed MM
Autologous stem cell transplant (ASCT) added to triple therapy improves progression-free survival (PFS) but not overall survival (OS) in patients with newly diagnosed multiple myeloma (MM), according to preliminary data from the...
Read More